{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009650","form_type":"8-K","ticker":"TEM","cik":"0001717115","company_name":"Tempus AI, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.988898+00:00","generated_at":"2026-05-16T10:54:10.224408+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tempus AI reports preliminary FY2025 revenue ~$1.27B (+83% YoY); TCV exceeds $1.1B","bullets":["FY2025 revenue ~$1.27B (+83% YoY); diagnostics ~$955M (+111%), data/apps ~$316M (+31%).","Q4 2025 revenue ~$367M (+83% YoY); diagnostics ~$266M (+121%), data/apps ~$100M (+25%).","Record total contract value >$1.1B as of Dec 31, 2025; net revenue retention ~126%.","Signed data agreements with >70 customers including AstraZeneca, Pfizer, Novartis, Merck, Eli Lilly, etc.","Preliminary results subject to change; final earnings call in Feb 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009650","json":"https://secwatch.observer/filing/0001193125-26-009650.json","markdown":"https://secwatch.observer/filing/0001193125-26-009650.md","text":"https://secwatch.observer/filing/0001193125-26-009650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/0001193125-26-009650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/d38597d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:54:10.224408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}